The global market for GMP Cytokines was valued at US$ 149 million in the year 2024 and is projected to reach a revised size of US$ 260 million by 2031, growing at a CAGR of 8.4% during the forecast period.
Cytokines are a large group of small signalling molecules that function extensively in cellular communication. Cytokines are most often associated with various immune modulating molecules that include interleukins, chemokines, and interferons, but can also include other molecules as well. GMP Cytokines are intended for use in GMP manufacturing of investigational or marketed clinical products, such as cell therapy, gene therapy, tissue-engineered products and other fields.
Drivers:
Increasing demand for cell and gene therapies: The rise of cell-based and gene therapies, such as CAR-T therapies and regenerative medicine, has significantly increased the demand for high-quality, GMP (Good Manufacturing Practice) cytokines. Cytokines play a crucial role in cell expansion and differentiation, making them essential in the manufacturing process of these therapies.
Growth in biopharmaceutical R&D: The pharmaceutical industry's focus on developing innovative biologics, cancer immunotherapies, and personalized medicine has led to a surge in demand for GMP-grade cytokines. These are critical for ensuring the consistency, safety, and effectiveness of drug development and clinical trials.
Advances in stem cell research: The expansion of stem cell research, which requires high-quality cytokines for the differentiation and proliferation of stem cells, has further driven the demand for GMP-grade cytokines in both academic and industrial research settings.
Regulatory requirements: The need for compliance with regulatory standards, especially in clinical trials and drug manufacturing, has heightened the demand for GMP-certified cytokines. These stringent standards ensure that cytokines used in clinical and therapeutic applications are of the highest purity and quality.
Rising interest in cancer immunotherapy: Cytokines are essential components in cancer immunotherapies, which harness the body鈥檚 immune system to fight cancer. As immunotherapy research grows, so does the demand for GMP cytokines, particularly in the production of therapies targeting immune modulation.
Challenges:
High production costs: Producing GMP-grade cytokines involves stringent quality controls and highly specialized manufacturing processes, which significantly increase production costs. This makes GMP cytokines expensive, limiting their accessibility, especially for smaller research institutions and companies.
Complexity of manufacturing: The production of GMP cytokines requires sophisticated technologies, including recombinant protein production, purification, and quality control processes, which can be complex and time-consuming. Any deviation in these processes can lead to batch failures, affecting supply chain stability.
Regulatory hurdles: Obtaining regulatory approvals for GMP cytokines used in clinical applications can be a lengthy and challenging process. Manufacturers must meet stringent quality and safety standards, which can delay the availability of new products and limit market growth.
Supply chain issues: The production of GMP cytokines is highly dependent on reliable and consistent raw material supplies. Any disruptions in the supply chain, such as shortages of critical raw materials, can impact production timelines and availability, posing a challenge to manufacturers.
Competition from alternative technologies: As new technologies emerge in the biopharmaceutical industry, such as synthetic biology and non-cytokine-based methods for cell growth and differentiation, the demand for traditional cytokines could be threatened, impacting market growth in the long term.
Report Scope
This report aims to provide a comprehensive presentation of the global market for GMP Cytokines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GMP Cytokines.
The GMP Cytokines market size, estimations, and forecasts are provided in terms of sales volume (mg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global GMP Cytokines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GMP Cytokines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Bio-Techne
PeproTech
CellGenix
Miltenyi Biotec
Cytiva
Lonza
ReproCELL
Sino Biological
Akron Biotech
Creative Bioarray
Segment by Type
TNF
Interleukin
Growth Factor
Others
Segment by Application
Cell/Gene Therapy
Tissue-Engineered Products
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of GMP Cytokines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of GMP Cytokines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 GMP Cytokines 麻豆原创 Overview
1.1 Product Definition
1.2 GMP Cytokines by Type
1.2.1 Global GMP Cytokines 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 TNF
1.2.3 Interleukin
1.2.4 Growth Factor
1.2.5 Others
1.3 GMP Cytokines by Application
1.3.1 Global GMP Cytokines 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Cell/Gene Therapy
1.3.3 Tissue-Engineered Products
1.3.4 Others
1.4 Global GMP Cytokines 麻豆原创 Size Estimates and Forecasts
1.4.1 Global GMP Cytokines Revenue 2020-2031
1.4.2 Global GMP Cytokines Sales 2020-2031
1.4.3 Global GMP Cytokines 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 GMP Cytokines 麻豆原创 Competition by Manufacturers
2.1 Global GMP Cytokines Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global GMP Cytokines Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global GMP Cytokines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of GMP Cytokines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of GMP Cytokines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of GMP Cytokines, Product Type & Application
2.7 Global Key Manufacturers of GMP Cytokines, Date of Enter into This Industry
2.8 Global GMP Cytokines 麻豆原创 Competitive Situation and Trends
2.8.1 Global GMP Cytokines 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest GMP Cytokines Players 麻豆原创 Share by Revenue
2.8.3 Global GMP Cytokines 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global GMP Cytokines 麻豆原创 Scenario by Region
3.1 Global GMP Cytokines 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global GMP Cytokines Sales by Region: 2020-2031
3.2.1 Global GMP Cytokines Sales by Region: 2020-2025
3.2.2 Global GMP Cytokines Sales by Region: 2026-2031
3.3 Global GMP Cytokines Revenue by Region: 2020-2031
3.3.1 Global GMP Cytokines Revenue by Region: 2020-2025
3.3.2 Global GMP Cytokines Revenue by Region: 2026-2031
3.4 North America GMP Cytokines 麻豆原创 Facts & Figures by Country
3.4.1 North America GMP Cytokines 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America GMP Cytokines Sales by Country (2020-2031)
3.4.3 North America GMP Cytokines Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe GMP Cytokines 麻豆原创 Facts & Figures by Country
3.5.1 Europe GMP Cytokines 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe GMP Cytokines Sales by Country (2020-2031)
3.5.3 Europe GMP Cytokines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific GMP Cytokines 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific GMP Cytokines 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific GMP Cytokines Sales by Region (2020-2031)
3.6.3 Asia Pacific GMP Cytokines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America GMP Cytokines 麻豆原创 Facts & Figures by Country
3.7.1 Latin America GMP Cytokines 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America GMP Cytokines Sales by Country (2020-2031)
3.7.3 Latin America GMP Cytokines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa GMP Cytokines 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa GMP Cytokines 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa GMP Cytokines Sales by Country (2020-2031)
3.8.3 Middle East and Africa GMP Cytokines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global GMP Cytokines Sales by Type (2020-2031)
4.1.1 Global GMP Cytokines Sales by Type (2020-2025)
4.1.2 Global GMP Cytokines Sales by Type (2026-2031)
4.1.3 Global GMP Cytokines Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global GMP Cytokines Revenue by Type (2020-2031)
4.2.1 Global GMP Cytokines Revenue by Type (2020-2025)
4.2.2 Global GMP Cytokines Revenue by Type (2026-2031)
4.2.3 Global GMP Cytokines Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global GMP Cytokines Price by Type (2020-2031)
5 Segment by Application
5.1 Global GMP Cytokines Sales by Application (2020-2031)
5.1.1 Global GMP Cytokines Sales by Application (2020-2025)
5.1.2 Global GMP Cytokines Sales by Application (2026-2031)
5.1.3 Global GMP Cytokines Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global GMP Cytokines Revenue by Application (2020-2031)
5.2.1 Global GMP Cytokines Revenue by Application (2020-2025)
5.2.2 Global GMP Cytokines Revenue by Application (2026-2031)
5.2.3 Global GMP Cytokines Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global GMP Cytokines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bio-Techne
6.1.1 Bio-Techne Company Information
6.1.2 Bio-Techne Description and Business Overview
6.1.3 Bio-Techne GMP Cytokines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bio-Techne GMP Cytokines Product Portfolio
6.1.5 Bio-Techne Recent Developments/Updates
6.2 PeproTech
6.2.1 PeproTech Company Information
6.2.2 PeproTech Description and Business Overview
6.2.3 PeproTech GMP Cytokines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 PeproTech GMP Cytokines Product Portfolio
6.2.5 PeproTech Recent Developments/Updates
6.3 CellGenix
6.3.1 CellGenix Company Information
6.3.2 CellGenix Description and Business Overview
6.3.3 CellGenix GMP Cytokines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 CellGenix GMP Cytokines Product Portfolio
6.3.5 CellGenix Recent Developments/Updates
6.4 Miltenyi Biotec
6.4.1 Miltenyi Biotec Company Information
6.4.2 Miltenyi Biotec Description and Business Overview
6.4.3 Miltenyi Biotec GMP Cytokines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Miltenyi Biotec GMP Cytokines Product Portfolio
6.4.5 Miltenyi Biotec Recent Developments/Updates
6.5 Cytiva
6.5.1 Cytiva Company Information
6.5.2 Cytiva Description and Business Overview
6.5.3 Cytiva GMP Cytokines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Cytiva GMP Cytokines Product Portfolio
6.5.5 Cytiva Recent Developments/Updates
6.6 Lonza
6.6.1 Lonza Company Information
6.6.2 Lonza Description and Business Overview
6.6.3 Lonza GMP Cytokines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Lonza GMP Cytokines Product Portfolio
6.6.5 Lonza Recent Developments/Updates
6.7 ReproCELL
6.7.1 ReproCELL Company Information
6.7.2 ReproCELL Description and Business Overview
6.7.3 ReproCELL GMP Cytokines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 ReproCELL GMP Cytokines Product Portfolio
6.7.5 ReproCELL Recent Developments/Updates
6.8 Sino Biological
6.8.1 Sino Biological Company Information
6.8.2 Sino Biological Description and Business Overview
6.8.3 Sino Biological GMP Cytokines Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sino Biological GMP Cytokines Product Portfolio
6.8.5 Sino Biological Recent Developments/Updates
6.9 Akron Biotech
6.9.1 Akron Biotech Company Information
6.9.2 Akron Biotech Description and Business Overview
6.9.3 Akron Biotech GMP Cytokines Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Akron Biotech GMP Cytokines Product Portfolio
6.9.5 Akron Biotech Recent Developments/Updates
6.10 Creative Bioarray
6.10.1 Creative Bioarray Company Information
6.10.2 Creative Bioarray Description and Business Overview
6.10.3 Creative Bioarray GMP Cytokines Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Creative Bioarray GMP Cytokines Product Portfolio
6.10.5 Creative Bioarray Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 GMP Cytokines Industry Chain Analysis
7.2 GMP Cytokines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 GMP Cytokines Production Mode & Process Analysis
7.4 GMP Cytokines Sales and 麻豆原创ing
7.4.1 GMP Cytokines Sales Channels
7.4.2 GMP Cytokines Distributors
7.5 GMP Cytokines Customer Analysis
8 GMP Cytokines 麻豆原创 Dynamics
8.1 GMP Cytokines Industry Trends
8.2 GMP Cytokines 麻豆原创 Drivers
8.3 GMP Cytokines 麻豆原创 Challenges
8.4 GMP Cytokines 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Bio-Techne
PeproTech
CellGenix
Miltenyi Biotec
Cytiva
Lonza
ReproCELL
Sino Biological
Akron Biotech
Creative Bioarray
听
听
*If Applicable.
